This website uses cookies. By using this website, you agree to our Cookie Policy.
June 14, 2024
Cadwalader’s Leveraged Finance & Private Credit team in London advised Amethyst Radiotherapy Group B.V in securing a landmark €300 million financing agreement with credit funds managed by Ares Management Corporation, a leading global alternative investment manager, announced on June 12.
As noted in their announcement, this investment positions Amethyst as a leading player in the European oncology sector, as it continues to accelerate its expansion. With clinics across seven countries in Europe, Amethyst is one of Europe’s fastest growing providers of private cancer treatment. The multijurisdictional nature of the borrower’s business provides a platform for Cadwalader to continue to demonstrate its ability to lead and coordinate complex multijurisdictional financing mandates to help the borrower and its shareholders achieve its future strategic initiatives.
The Cadwalader team was led by Matthew Smith and included associates Matthew Mazenier, Michael El Gawly and Harriet Geddis, and paralegals Elias Ojja and Jusmin Lama.
